Literature DB >> 28017970

Unnatural C-1 homologues of pancratistatin - Synthesis and promising biological activities.

Sergey Vshyvenko1, Jon Scattolon1, Tomas Hudlicky1, Anntherese E Romero2, Alexander Kornienko2, Dennis Ma3, Ian Tuffley3, Siyaram Pandey3.   

Abstract

Several C-1 homologues of pancratistatin and 7-deoxypancratistatin were synthesized by a phenanthrene-phenathridone oxidative recyclization strategy. The key steps involved the enzymatic dihydroxylation of bromobenzene, addition of an aryl alane to an epoxyaziridine, an intramolecular aziridine opening on silica gel in solid phase, and the above-mentioned recylization strategy. Experimental and spectral data are reported for all new compounds. All synthesized C-1 homologues of pancratistatin and 7-deoxypancratistatin were evaluated for antiproliferative activity in a panel of human cancer cell lines. As expected, the 7-hydroxy compounds were found to be more potent and the activity of the C-1 benzoxymethyl analogue exceeded that of narciclasine, which was used as a positive control.

Entities:  

Keywords:  C-1 homologues of pancratistatin; amaryllidaceae alkaloids; anticancer activities; intramolecular aziridine opening; solid-phase silica catalysis

Year:  2012        PMID: 28017970      PMCID: PMC5176109          DOI: 10.1139/v2012-073

Source DB:  PubMed          Journal:  Can J Chem        ISSN: 0008-4042            Impact factor:   1.118


  30 in total

1.  A synthesis of 3-deoxydihydrolycoricidine: refinement of a structurally minimum pancratistatin pharmacophore.

Authors:  James McNulty; Vladimir Larichev; Siyaram Pandey
Journal:  Bioorg Med Chem Lett       Date:  2005-09-23       Impact factor: 2.823

2.  Synthesis of buprenorphine from oripavine via N-demethylation of oripavine quaternary salts.

Authors:  Lukas Werner; Ales Machara; David R Adams; D Phillip Cox; Tomas Hudlicky
Journal:  J Org Chem       Date:  2011-05-02       Impact factor: 4.354

3.  Total synthesis of (+)-trans-dihydronarciclasine by a catalytic enantioselective regiodivergent nitroso Diels-Alder reaction.

Authors:  Chandan Kumar Jana; Armido Studer
Journal:  Chemistry       Date:  2008       Impact factor: 5.236

4.  Potent and selective inhibition of human cytochrome P450 3A4 by seco-pancratistatin structural analogs.

Authors:  James McNulty; Jerald J Nair; Mohini Singh; Denis J Crankshaw; Alison C Holloway
Journal:  Bioorg Med Chem Lett       Date:  2010-02-04       Impact factor: 2.823

5.  Structure-activity studies on acetylcholinesterase inhibition in the lycorine series of Amaryllidaceae alkaloids.

Authors:  James McNulty; Jerald J Nair; Jessamyn R L Little; John D Brennan; Jaume Bastida
Journal:  Bioorg Med Chem Lett       Date:  2010-07-01       Impact factor: 2.823

6.  Antineoplastic agents. 587. Isolation and structure of 3-epipancratistatin from Narcissus cv. Ice Follies.

Authors:  George R Pettit; Rui Tan; Guan-Hu Bao; Noeleen Melody; Dennis L Doubek; Song Gao; Jean-Charles Chapuis; Lee Williams
Journal:  J Nat Prod       Date:  2012-03-13       Impact factor: 4.050

7.  TOTAL SYNTHESES OF PANCRATISTATIN. A REVIEW.

Authors:  Madhuri Manpadi; Alexander Kornienko
Journal:  Org Prep Proced Int       Date:  2009-02-18       Impact factor: 1.628

8.  synthesis and biological evaluation of fully functionalized seco-pancratistatin analogues.

Authors:  James McNulty; Jerald J Nair; Carly Griffin; Siyaram Pandey
Journal:  J Nat Prod       Date:  2008-01-29       Impact factor: 4.050

9.  Synthesis of structurally simplified analogues of pancratistatin: truncation of the cyclitol ring.

Authors:  Madhuri Manpadi; Artem S Kireev; Igor V Magedov; Jeff Altig; Paul Tongwa; Mikhail Yu Antipin; Antonio Evidente; Willem A L van Otterlo; Alexander Kornienko
Journal:  J Org Chem       Date:  2009-09-18       Impact factor: 4.354

10.  Antineoplastic agents 320: synthesis of a practical pancratistatin prodrug.

Authors:  G R Pettit; S Freeman; M J Simpson; M A Thompson; M R Boyd; M D Williams; G R Pettit; D L Doubek
Journal:  Anticancer Drug Des       Date:  1995-04
View more
  6 in total

1.  Design and Synthesis of C-1 Methoxycarbonyl Derivative of Narciclasine and Its Biological Activity.

Authors:  Lihi Habaz; Korey Bedard; Mitchell Smith; Liqin Du; Alexander Kornienko; Tomas Hudlicky
Journal:  Molecules       Date:  2022-06-14       Impact factor: 4.927

2.  5,10b-Ethanophenanthridine amaryllidaceae alkaloids inspire the discovery of novel bicyclic ring systems with activity against drug resistant cancer cells.

Authors:  Sean Henry; Ria Kidner; Mary R Reisenauer; Igor V Magedov; Robert Kiss; Véronique Mathieu; Florence Lefranc; Ramesh Dasari; Antonio Evidente; Xiaojie Yu; Xiuye Ma; Alexander Pertsemlidis; Regina Cencic; Jerry Pelletier; David A Cavazos; Andrew J Brenner; Alexander V Aksenov; Snezna Rogelj; Alexander Kornienko; Liliya V Frolova
Journal:  Eur J Med Chem       Date:  2016-05-06       Impact factor: 6.514

3.  Asymmetric Entry into 10b-aza-Analogues of Amaryllidaceae Alkaloids Reveals a Pronounced Electronic Effect on Antiviral Activity.

Authors:  Carla E Brown; Tiffany Kong; James F Britten; Nick H Werstiuk; James McNulty; Leonardo D'Aiuto; Matthew Demers; Vishwajit L Nimgaonkar
Journal:  ACS Omega       Date:  2018-09-20

Review 4.  Benefits of Unconventional Methods in the Total Synthesis of Natural Products.

Authors:  Tomas Hudlicky
Journal:  ACS Omega       Date:  2018-12-14

5.  Conversion of Natural Narciclasine to Its C-1 and C-6 Derivatives and Their Antitumor Activity Evaluation: Some Unusual Chemistry of Narciclasine.

Authors:  Juana Goulart Stollmaier; Jared Thomson; Mary Ann Endoma-Arias; Razvan Simionescu; Alexandra Vernaza; Nakya Mesa-Diaz; Mitchell Smith; Liqin Du; Alexander Kornienko; Tomas Hudlicky
Journal:  Molecules       Date:  2022-06-28       Impact factor: 4.927

6.  Stereoselective synthesis of trans-dihydronarciclasine derivatives containing a 1,4-benzodioxane moiety.

Authors:  Gábor Varró; Balázs Pogrányi; Alajos Grün; András Simon; László Hegedűs; István Kádas
Journal:  Monatsh Chem       Date:  2018-10-26       Impact factor: 1.451

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.